Close

Intra-Cellular Therapies (ITCI): CNS Summit Data Supports KOL Observations, Reit Overweight - PiperJaffray

Go back to Intra-Cellular Therapies (ITCI): CNS Summit Data Supports KOL Observations, Reit Overweight - PiperJaffray
INTRA-CELL THRP (NASDAQ: ITCI) Delayed: 72.19 -0.93 (1.27%)
Previous Close $73.12    52 Week High $59.96 
Open $72.46    52 Week Low $10.80 
Day High $72.78    P/E N/A 
Day Low $71.35    EPS $0.00 
Volume 525,498